How Community Pharmacists can help patients on Antidepressants at risk for suicides and sexual dysfunction
Saad Salman1★, Abdullah A1, Jawaria Idrees2, Fahad Hassan Shah3★ Corresponding author
- 1Department of Pharmacy, Abasyn University, Peshawar, PAKISTAN.
- 2Department of Integrated Sciences, Post Graduate College of Nursing Peshawar, PAKISTAN.
- 3Centre of Biotechnology and Microbiology, University of Peshawar, Peshawar, PAKISTAN.
CORRESPONDENCE
Saad Salman
Department of Pharmacy, Abasyn University, Peshawar, PAKISTAN.
Received: 20-02-2016; Revised: 01-03-2016; Accepted: 10-03-2016.
Volume 2, Issue 3 · pp. 100–101 · PUBLISHED · DOI: 10.5530/jppcm.2016.3.8
ABSTRACT
Widespread use of antidepressant drugs has led to suicidal attempts and sexual dysfunction among adolescent psychiatric patients.[1] Patients usually complain for delayed ejaculation and libido loss with SSRIs group specifically. [2] Although in premature ejaculation these drugs have significant impact, but still they are risky for many patients; if they are not well aware of the considerable side effects these drugs carry along. Adolescents are usually victimized by such side effects like suicidal intents, non-compliance, drug denial and this may ultimately result in behavioral disorders.[3] Educating the patient and his relatives regarding these potential side effectsis very necessary for the pharmacist.[4] The mortality rate of adolescents with depression is highly contributed by these side effects. The foremost culprit for adolescent mortality was tricyclic and SSRI’s use in the US.[2,4] So application of appropriate actions is need of the day while prescribing these drugs.[5-6]
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Salman, S., A, A., Idrees, J., & Shah, F. H. (). How Community Pharmacists can help patients on Antidepressants at risk for suicides and sexual dysfunction. Journal of Pharmacy Practice and Community Medicine, 2(3), 100–101. https://doi.org/10.5530/jppcm.2016.3.8
